Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1787 Triple Negative Breast Neoplasms 301 Ovarian Neoplasms 136 Lung Neoplasms 116 Colorectal Neoplasms 115 Neoplasms 106 Prostatic Neoplasms 104 Carcinoma, Non-Small-Cell Lung 102 Neoplasm Metastasis 96 Stomach Neoplasms 81 Pancreatic Neoplasms 78 Melanoma 74 Endometrial Neoplasms 65 Head and Neck Neoplasms 60 Uterine Cervical Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 50 Colonic Neoplasms 45 Esophageal Neoplasms 42 Sarcoma 41 Carcinoma, Intraductal, Noninfiltrating 41 Motor Activity 37 HER2-positive Breast Cancer 35 Urinary Bladder Neoplasms 34 Liver Neoplasms 31 Carcinoma, Renal Cell 30 Brain Neoplasms 28 Kidney Neoplasms 25 Advanced Breast Cancer 25 Lymphedema 24 Carcinoma, Transitional Cell 23

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hormone Receptor Positive Breast Cancer × Breast × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡